Endonovo Therapeutics Inc (ENDV)

[Biotech_Tradez]

The toxic lender has almost $6 million in convertible debt that he has to sell.

This POS is done, put a fork in this pig it is ready to be roasted.

They increased the authorized to 2 billion shares for a reason, they knew they were going to dilute the $hit out of this, yet they were PR'ing last quarter that they were going to uplist and they hired a banker to raise them $10m to buy out the note.

A lot of pin heads bought into their BS and now that it is clear what is happening, ENDV management is resorting to putting out PR's up to twice per week. Once they realize it is not working, they will pay for more article to pump up the stock.